Immucell share price logo

Immucell

NASDAQ: ICCC

$10.09

+0.33

(+3.38%)

as on

Immucell Stock Performance

as on August 20, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $9.61
    $10.38
    downward going graph

    4.76%

    Downside

    2.87%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.52
    $12.10
    downward going graph

    55.20%

    Downside

    19.92%

    Upside

    downward going graph

Immucell share price movements today

Previous Close
$9.76
Open
$9.83
Volume
113.9K
Market Cap
$91.3M
Day's Low - High
$9.61 - $10.38
52 Week Low - High
$4.52 - $12.10

Immucell Historical Returns

1 Month Return
-9.66 %
3 Month Return
+ 12.67 %
1 Year Return
+ 64.67 %
3 Year Return
+ 101 %
5 Year Return
+ 9.15 %

Immucell Stock Fundamentals & Key Indicators

Check Immucell market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$91.3M

EPS (TTM)

-0.0554

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

2.60%

PE Ratio (TTM)

128.84

Industry PE ratio

-1.5966015625

PEG Ratio

-0.3321392307161329

EBITDA

2.4M

Revenue (TTM)

29.9M

Profit Margin

40.32%

Return On Equity TTM

2.68%

Immucell Stock Valuation

Track how Immucell P/E has moved over time to understand its valuation trends.

Immucell in the last 5 years

  • Overview

  • Trends

Lowest (-775.80x)

December 31, 2021

Today (-51.25x)

December 31, 2025

Industry (-1.60x)

December 31, 2025

Highest (-6.79x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -51.25x

Immucell vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immucell with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$91.3M9.15%128.8440.32%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Immucell Stock including INR - Dollar returns

The Immucell stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immucell investment value today

Current value as on today

₹1,81,797

Returns

₹81,797

(+81.8%)

Returns from Immucell Stock

₹65,329 (+65.33%)

Dollar Impact

₹16,468 (+16.47%)

Analyst Recommendation on Immucell Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Immucell. Average target price of $14

Immucell Share Price Target

Get share price movements and forecasts by analysts on Immucell.

What analysts predicted

27.93%UPSIDE

Target Price

$14

Current Price

$10.09

Analyzed by

7 Analysts

Target

$14.00

Immucell target price $14, a slight upside of 27.93% compared to current price of $10.09. According to 7 analysts rating.

Indian Investors' Interest in Immucell Stock

Search interest for Immucell Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-54% versus previous 30 day period

Immucell Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
5
7
5
6
7
8
6
5
7
10
Gross Profit
1
2
1
1
2
3
2
2
2
4
Operating Income
-1
0
-1
0
0
1
0
0
0
1
EBITDA
0
0
0
0
1
2
1
0
-2
2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
0
-1
0
0
1
0
0
-2
1
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-1
0
-1
0
0
1
0
0
-2
1
Net Profit Margin
24.69%
31.63%
22.48%
26.34%
36.53%
41.58%
43.72%
42.92%
38.16%
44.97%

Immucell Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
10
10
13
15
19
18
17
26
27
Gross Profit
5
5
6
6
8
7
4
7
11
Operating Income
0
-1
0
-1
0
-2
-5
-1
1
EBITDA
0
0
1
1
2
0
-2
1
2
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
0
1
2
2
2
2
2
2
2
Income Before Tax
0
-1
-1
-1
0
-2
-5
-2
-1
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
0
-2
-1
-1
0
-2
-5
-2
-1
Net Profit Margin
50.05%
47.28%
49.11%
44.73%
44.98%
41.19%
25.16%
29.97%
41.40%

Immucell Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-1
0
-1
0
0
1
0
0
-2
1
Operating Cash Flow
0
0
0
0
0
1
1
-1
0
3
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
3
0
0
0
0
0
0
Change in Cash
-1
0
0
2
0
0
1
-2
0
3

Immucell Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-2
-1
-1
0
-2
-5
-2
-1
Operating Cash Flow
1
0
0
1
0
-1
-4
0
2
Investing Cash Flow
-12
-1
-3
-2
-1
-3
-1
0
-1
Financing Cash Flow
9
0
6
1
3
1
1
2
-1
Change in Cash
-1
-1
3
0
3
-4
-4
2
0

Mutual Funds that own Immucell Stock

Check out the Mutual Funds with significant holdings in Immucell.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.877559%
260327
Fidelity Concord Street Trust
0.651202%
58913
DFA INVESTMENT DIMENSIONS GROUP INC
0.313226%
28337
Nationwide Mutual Funds
0.111663%
10102

Global Institutional Holdings in Immucell

Funds
Holdings
Vanguard
2.87%
iShares
0.23%
Dimensional
0.08%

Immucell News & Key Events

    Insights on Immucell

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Revolution Medicines, Inc. Common Stock has given 629.2% return, outperforming this stock by 533.6%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Revolution Medicines, Inc. Common Stock has given 491.1% return, outperforming this stock by 425.7%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, 1.94M → 1.83M (in $), with an average decrease of 5.5% per quarter

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, ICCC stock has moved down by -11.1%

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 2 quarters, 10.35M → 7.18M (in $), with an average decrease of 30.6% per quarter

    About Immucell

    ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, the company developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is based in Portland, Maine.
    OrganisationImmucell
    Headquarters56 Evergreen Drive, Portland, ME, United States, 04103
    IndustryBiotechnology
    CEOMr. Paul F. Olivier Te Boekhorst
    E-voting on sharesClick here to vote

    Key Management of Immucell

    Name

    Title

    Mr. Timothy C. Fiori

    CFO, Secretary & Treasurer

    Ms. Bobbi Jo Brockmann

    Senior Vice President of Sales & Marketing

    Ms. Elizabeth S. Toothaker

    Director of Finance & Administration and Controller

    Mr. A. Gustavo Scaffa

    Senior Director of Quality

    John W. Zinckgraf

    Director of Product Development

    Mr. Paul F. Olivier Te Boekhorst

    President, CEO & Director

    FAQs

    What is Immucell share price today?

    Immucell share price today is $10.09 as on at the close of the market. Immucell share today touched a day high of $10.38 and a low of $9.61.

    What is the 52 week high and 52 week low for Immucell share?

    Immucell share touched a 52 week high of $12.10 on and a 52 week low of $4.52 on . Immucell stock price today i.e. is closed at $10.09,which is 16.61% down from its 52 week high and 123.23% up from its 52 week low.

    What is Immucell's market capitalisation today?

    Immucell market capitalisation is $0.00T as on .

    How to invest in Immucell Stock (ICCC) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Immucell on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immucell Shares that will get you 0.1487 shares as per Immucell share price of $10.09 per share as on August 20, 2026 at 1:29 am IST.

    What is the minimum amount required to buy Immucell Stock (ICCC) from India?

    Indian investors can start investing in Immucell (ICCC) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹957.43 in Immucell stock (as per the Rupee-Dollar exchange rate as on ). Based on Immucell share’s latest price of $10.09 as on August 20, 2026 at 1:29 am IST, you will get 0.9911 shares of Immucell. Learn more about fractional shares .

    What are the returns that Immucell has given to Indian investors in the last 5 years?

    Immucell stock has given 9.15% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?